Vitestro, developer of an autonomous blood drawing device, has completed a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry. The proceeds will be used to accelerate product development, prepare EU market authorization, and initiate production. Olym advised Sonder Capital on this investment.

3T, an Italian manufacturer of road and gravel bicycles, is bringing UTurn Investments on board to fund its international expansion plans. The investment also allows 3T to ramp up Italian production of strategic and innovative products, such as the signature carbon frames “RaceMax Italia”. The company will continue to be led by René Wiertz and Gérard Vroomen. We advised 3T in this transaction.

Enzyre, which is developing breakthrough ambulant diagnostic technology for blood coagulation testing, has raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment as technology partner and existing investors, Takeda Ventures and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government. The proceeds from the financing will enable Enzyre to further develop its unique diagnostic technology platform, EnzyPad, which will enable hemophilia patients to determine and monitor their coagulation status from home in real-time. Olym advised Enzyre in this funding round.

FlexiDAO, a leading software provider for 24/7 electricity and carbon tracking, has secured a $6.5 million investment round led by SET Ventures, with investment from Google and the Microsoft Climate Innovation Fund, and existing investor EIT InnoEnergy. FlexiDAO enables companies and governments to operate on round-the-clock carbon-free energy, by certifying and tracing their electricity and its true carbon content, every hour of every day. We advised lead investor SET Ventures on this series A investment round.

We advised Thorizon on its 12.5 million euro funding round for the development of a new generation of nuclear power plants. The ‘Thorium molten salt reactor’ developed by Thorizon will use long-lived waste in combination with the abundant metal Thorium as fuel. This makes the reactor capable of making an important contribution to a safe, virtually inexhaustible and CO2-free energy supply. The investors are a strong team of private and public sector parties, including Positron Ventures, Invest-NL, Huisman, PDENH and Impuls Zeeland.

Energy Trading Platform Amsterdam B.V. (ETPA) has been awarded a license to operate as a pan-European intraday energy exchange. By making energy trading faster and cheaper, ETPA’s intraday trading platform contributes to a flexible energy system that can absorb more energy from renewable sources. With the license, the company can expand its reach and offer services to energy traders across Europe. To support its international growth ambitions, ETPA raised € 5 million in growth financing from energy transition expert SET Ventures and sustainable finance leader ABN AMRO Sustainable Impact Fund. We advised ETPA on this transaction.

Axion BioSystems is a US-based life sciences tools company focused on advanced live-cell assay systems and a portfolio company of Summa Equity. Axion BioSystems has acquired CytoSMART, a Dutch biotechnology company focused on kinetic live-cell imaging analysis. The acquisition of CytoSMART puts Axion in a position for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. We advised CytoSMART and its selling shareholders, including Holland Capital, BOM and ECFG (Eindhoven Corporate Finance Group), on this transaction.

Trunkrs, specialist in Same Day & Next Day delivery for the e-commerce sector, has successfully raised EUR 15 million in a Series B financing round. This financing round was led by Korys, the Belgian investment company of the Colruyt family. In addition to Korys, VP Capital, the family office of the Van Puijenbroek family, and SET Ventures, which previously invested in Trunkrs, also invested. We advised SET Ventures in this transaction.

We advised SET Ventures in its investment, jointly with FORWARD.one and Korys, in the Utrecht-based climate scale-up Sensorfact. Sensorfact helps companies in the manufacturing industry to save up to 15% on energy bills with intelligent energy management and energy-saving advice.

LeydenJar Technologies, a Dutch start-up originating from TNO that has developed battery technology based on 100% silicon anodes, has raised € 22 million in a new financing round for further development and upscaling. The capital was provided by a consortium of investors consisting of YARD ENERGY, Catalus Capital, Invest-NL, ING Sustainable Investments and Somerset Capital Partners together with a number of existing shareholders (including BOM, DOEN participaties and PVS Investments). We advised lead investor YARD ENERGY and the consortium of investors.